NASDAQ:NTRA Natera (NTRA) Stock Price, News & Analysis $289.92 +0.42 (+0.15%) Closing price 11/19/2026 04:00 PM EasternExtended Trading$290.24 +0.32 (+0.11%) As of 11/19/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Natera Stock (NASDAQ:NTRA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Natera alerts:Sign Up Key Stats Today's Range$288.20▼$307.1950-Day Range$287.47▼$436.0052-Week Range$181.00▼$437.41Volume2.73 million shsAverage Volume2.28 million shsMarket Capitalization$42.04 billionP/E RatioN/ADividend YieldN/APrice Target$394.31Consensus RatingModerate Buy Company Overview Natera, Inc. is a diagnostics company that develops and provides genetic testing and molecular diagnostics for reproductive health, oncology and organ health. Its tests analyze cell-free DNA and other genetic material to support screening, diagnosis and disease monitoring. In reproductive health, Natera offers Panorama, a noninvasive prenatal screening test, and Horizon, a carrier screening test. Its oncology portfolio includes Signatera, a personalized circulating tumor DNA test used to monitor for molecular residual disease and assess cancer recurrence. The company also provides Prospera, a molecular test used to help assess organ transplant rejection. Founded in 2004, Natera serves healthcare providers and patients in the United States and internationally. Steve Chapman is the company’s chief executive officer.AI Generated. May Contain Errors. Read More Natera Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreNTRA MarketRank™: 2.92906336088 of 5 starsNatera scored higher than 59% of companies evaluated by MarketBeat, and ranked 292nd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingNatera has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 2 strong buy ratings, 17 buy ratings, 2 hold ratings, and 2 sell ratings.Upside PotentialNatera has a consensus price target of $394.31, representing about 36.0% upside from its current price of $289.92.Amount of Analyst CoverageNatera has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Natera's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Natera are expected to grow in the coming year, from ($1.25) to ($0.15) per share.Price to Book Value per Share RatioNatera has a P/B Ratio of 22.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.44% of the float of Natera has been sold short.Short Interest Ratio / Days to CoverNatera has a short interest ratio ("days to cover") of 4.15.Change versus previous monthShort interest in Natera has recently increased by 3.77%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNatera does not currently pay a dividend.Dividend GrowthNatera does not have a long track record of dividend growth. News and Social Media1.5 / 5News Sentiment0.36 News SentimentNatera has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Natera this week, compared to 10 articles on an average week.Search InterestOnly 16 people have searched for NTRA on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Natera to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Natera insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $17,760,989.00 in company stock.Percentage Held by Insiders5.05% of the stock of Natera is held by insiders.Percentage Held by Institutions99.90% of the stock of Natera is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Natera's insider trading history. Receive NTRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Natera and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NTRA Stock News HeadlinesNatera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027?November 19 at 2:20 PM | fool.comHLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening & Early DetectionNovember 18 at 8:32 AM | marketscreener.comMWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected. | Porter & Company (Ad)iMDx Reports Progress on FDA Review of GraftAssureDx, GALACTIC Enrollment and Q3 2026 ResultsNovember 16, 2026 | quiverquant.comQNatera (NASDAQ:NTRA) Stock: Insider John Fesko Sells 302 SharesNovember 5, 2026 | insidertrades.comNatera (NASDAQ:NTRA) Stock: Insider Michael Burkes Brophy Sells 1,178 SharesNovember 3, 2026 | insidertrades.comNatera (NASDAQ:NTRA) CFO Sells $811,098.30 in StockOctober 31, 2026 | insidertrades.comNatera (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 781 Shares of Company StockOctober 30, 2026 | insidertrades.comSee More Headlines NTRA Stock Analysis - Frequently Asked Questions How have NTRA shares performed this year? Natera's stock was trading at $229.09 at the beginning of the year. Since then, NTRA stock has increased by 26.6% and is now trading at $289.92. How were Natera's earnings last quarter? Natera, Inc. (NASDAQ:NTRA) posted its quarterly earnings results on Thursday, November, 5th. The medical research company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by $0.14. The firm's revenue was up 34.1% compared to the same quarter last year. Read the conference call transcript. When did Natera IPO? Natera (NTRA) raised $175 million in an initial public offering (IPO) on Thursday, July 2nd 2015. The company issued 10,000,000 shares at $17.00-$18.00 per share. Morgan Stanle, Cowen and Company and Piper Jaffray acted as the underwriters for the IPO and Baird and Wedbush Pacgrow were co-managers. Who are Natera's major shareholders? Natera's top institutional investors include State Street Corp (2.54%), Aberdeen Group plc (0.97%), Sumitomo Mitsui Trust Group Inc. (0.37%) and First Trust Advisors LP (0.36%). Insiders that own company stock include Roelof Botha, Matthew Rabinowitz, Daniel Rabinowitz, John Fesko, Solomon Moshkevich, Steven Leonard Chapman, Jonathan Sheena, Michael Burkes Brophy, James Healy, Roy D Baynes, Gail Boxer Marcus, Herm Rosenman and Rowan E Chapman. View institutional ownership trends. How do I buy shares of Natera? Shares of NTRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Natera own? Based on aggregate information from My MarketBeat watchlists, some other companies that Natera investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Broadcom (AVGO), CrowdStrike (CRWD) and Visa (V). Company Calendar Last Earnings11/05/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 4 days ago, NTRA's financial health entered the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:NTRA CIK1604821 Webwww.natera.com Phone(650) 249-9090FaxN/AEmployees6,140Year Founded2004Price Target and Rating Average Price Target for Natera$394.31 High Price Target$500.00 Low Price Target$245.00 Potential Upside/Downside+36.0%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)($1.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$208.16 million Net Margins-5.66% Pretax Margin-7.73% Return on Equity-8.61% Return on Assets-5.93% Debt Debt-to-Equity RatioN/A Current Ratio2.81 Quick Ratio2.66 Sales & Book Value Annual Sales$2.31 billion Price / Sales18.23 Cash FlowN/A Price / Cash FlowN/A Book Value$12.89 per share Price / Book22.49Miscellaneous Outstanding Shares145,010,000Free Float137,682,000Market Cap$42.04 billion OptionableOptionable Beta1.55 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:NTRA) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.